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ABSTRACT 
Polyethylene Oxide (PEOs) offer specific advantages to be used in pharmaceutical products as release modifiers by forming a hydrogel around 
the dosage form in aqueous environment causing the drug to follow a diffusional path before releasing into the media. The strength of the 
hydrogel governs the release retardation capacity of the PEO system. The objective of this dissertation work was to use the Design of 
Experiments methodology to develop and optimize a PEO based modified release formulation of a highly water-soluble drug like Metoprolol 
succinate. The effect of the different viscosity grade PEOs, their concentration with respect to the drug, combination of two different viscosity 
grades, % drug content in the formulation and the use of water soluble / insoluble fillers on the dissolution of metoprolol succinate was 
studied. The critical formulation parameters namely PEO concentration and % drug content were chosen as input factors and dissolution at 1, 
4, 8 and 20 hours was recorded as responses to carry out optimization using the DOE approach. The results obtained after statistical treatment 
of data provided a design space that can be used for achieving the desired formulation profile. The model has been validated to predict the 
effect of the input factors (PEO type and concentration and % drug content) on the responses (in vitro dissolution).  
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INTRODUCTION 
Modified drug delivery is a domain which requires high 
degree of skill and understanding in order to regulate the 
release of the pharmaceutical compound. More often than 
not, the therapeutic dosing requirement governs whether a 
particular compound has to be given as a modified drug 
delivery or as a conventional immediate release dosage 
form. There can be numerous reasons due to which, the rate 
of release of the drug from the dosage form needs to be 
controlled; Primary being to have the drug into systemic 
circulation at a constant rate for a prolonged period of time 
so that it elicits a continuous pharmaceutical activity. The 
drugs with shorter half life, higher doses with narrow 
therapeutic window, are ideal candidates for delivery as 
modified release systems. In order to formulate a modified 
release delivery system, the right combination of scientific 
principles can in turn help effect the desired kind of release 
of the drug from the dosage form and thus deliver the drug 
at the rate and amount as desired or as most beneficial to 
the body1-3. Based on the mechanism of drug release from 
the modified release drug delivery systems, they can be 
classified as Diffusion controlled (matrix and reservoir type 
of systems) Dissolution controlled, (surface eroding, surface 
swelling type of systems), Osmotic drug delivery, Multi 
particulate systems, Enteric coated (pH dependent 
systems). Generally, the mechanism of drug release from 
any kind of modified release delivery system is governed by 
either of the above mechanisms. The regulation of drug 
release is achieved by incorporating release retarding 
agents into the formulations. The most widely used release 
retarding agents are polymers like high viscosity HPMC for 
diffusion and dissolution-controlled systems, or pH 
sensitive polymers like Eudragits and Ethyl cellulose for 
enteric coated and Multi particulate systems. Osmotic drug 
delivery systems involve controlling the release by 
incorporating an osmogen and a semi permeable membrane 
into the formulation in order to have a zero order 
continuous release from the medication 4-6. 
The comparatively less explored approach for regulation of 
the release from the formulation is the use of Polyoxy 
ethylene oxides (PEOs) resins. These are available under 
the brand name of Polyox® and are free flowing and 
directly compressible powders that form a Hydrogel around 
the formulation when contact with aqueous environment 
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and help in retarding the release of the API from the 
formulation. They are available in various different 
viscosity grades based on their molecular weights. They are 
relatively easy to process into dosage forms because of their 
free flowing and directly compressible nature and can be 
used as mere fillers in the tablets in order to act as release 
retardants. Thus, using PEOs in the formulation does not 
involve complex set of criticial process variables as 
observed in case of preparing a matrix, reservoir or a MUPS 
based delivery system7-9. The purpose of this Research 
work would be to apply design of experiments (DOE) 
approach to development and optimization of a Polyox 
based modified release drug delivery system of a highly 
water-soluble drug. In order to evaluate the effect of Polyox 
on the release modulation of the drug in the formulation, a 
model drug was chosen by screening a variety of drug 
molecules to meet certain pre-defined criteria as mentioned 
below 
 High solubility and high permeability i.e. BCS class I 
drug. (i.e absorption is not solubility or permeability 
dependent). 
 Biological half life (t1/2) between 2-6 hours to avoid 
accumulation in the body. Shorter t1/2 will ensure rapid 
clearance after absorption, thus negating any dose 
related side effects. 
 Moderate dose of between 50-150 mg per unit. 
 Drug for which use of extensive and elaborative coating 
process may not be a feasible approach. 
Based on the above criteria, Metoprolol succinate was 
selected as a model drug to evaluate and optimize the 
formulation related variables associated with polyethylene 
oxide. 
MATERIALS AND METHODS 
Materials: The Active pharmaceutical ingredient - 
Metoprolol succinate used for the study was manufactured 
by Ipca Laboratories Ltd. Polyethelene oxide polymers were 
obtained as gift samples from Alpa laboratories ltd India. 
The other ingredients Prosolv HD 90, directly compressible 
lactose (Supertab 21), and magnesium stearate were 
purchased from sources JRS Pharma, Fontenna Excipients 
and Signet Pharma respectively by Ipca laboratories ltd. 
Process of preparation of experimental formulations: 
The process of preparation of the formulations involved 
dispensing of raw materials and active, followed by co-
sifting, mixing and then compression into tablets. A brief 
step wise description of the manufacturing process is as 
mentioned below. 
Procedure: Dispense the drug substance as per batch 
requirement. Sift the drug substance through a # 50 sieve. 
Dispense the excipients (PEO, Prosolv HD 90 or DCL 21) as 
per batch requirement. 
Co-Sift the excipients along with API through # 50 sieve 2 -3 
times. Load the blend into the blender and Mix blend for 10 
min. Add required quantity of magnesium stearate (sifted 
through # 50 sieve) and blend for another 5 min. Compress 
tablets equivalent to make 100 mg Metoprolol succinate. A 
flow chart of the manufacturing procedure is depicted 
below. 
 
Figure 1: Flow chart for manufacturing of Metoprolol 
succinate PEO tablets 
Analytical methodology: The analytical methodology 
for in vitro drug dissolution was adapted from the Official 
USP monograph for Metorpolol succinate extended release 
tablets. The tablets were analyzed for content of metoprolol 
succinate in the dissolution medium. The details of the 
method are as mentioned below 
In vitro Dissolution method: The in vitro dissolution 
analysis was carried out in pH 6.8 phosphate buffer, 500 ml 
in USP type II paddle Apparatus at 50 rpm. The samples 
were withdrawn using auto sampler at 1, 4, 8, 12, 20 hours. 
The volume of samples withdrawn was replaced by 
additional media from replacement bowl. 
HPLC analysis: The HPLC analysis was carried out using a 4 
mm X 12.5 cm column containing C18 packing. The mobile 
phase of pH 3.0 phosphate buffer: Acetonitrile (375:125) 
was used for elution at a flow rate of 1 ml/min. The 
wavelength of absorption was determined using a PDA 
detector in the HPLC where Metoprolol succinate showed 
two maxima at wavelengths of 222 nm and 275 nm. The 
222 nm maxima showed a greater response and hence it 
was chosen as the wavelength for estimation for all the 
dissolution samples. 
Preparation of pH 3 Phosphate buffer: Mixed 50ml of 1M 
monobasic sodium phosphate and 8.0 ml of 1M phosphoric 
acid and diluted with water to 1000 ml. Adjusted pH to 3.0 
with 1M monobasic potassium phosphate or 1M phosphoric 
acid. 
Preparation of standard solution: Dissolved 50 mg 
accurately weighed Metoprolol succinate in Mobile Phase to 
obtain a solution of known concentration of about 0.05 mg 
per ml (i.e. 50 ppm). 20 µl of injection volume was used to 
determine the response. 
Preparation of sample solution: The 2 ml aliquot from the 
samples collected in at each time point in dissolution vial 
and diluted with the dissolution medium to 5 ml in a 
volumetric flask. Injected 20 µl of sample solution in the 
HPLC column. The standard curve was prepared to 
determine the linearity of the response area (area under the 
peak) across different concentrations and the R2 value was 
found to be 0.998. The figure 2 below depicts the standard 
linearity graph. 
 
Figure 2: Standard Response linearity with respect to 
concentration
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Figure 3: Chromatograms of the standard, blank and sample 
RESULTS AND DISCUSSION 
The results  of the experimental formulations were 
compiled in the DOE response sheet in the Design expert ® 
software screen as mentioned in the Figure 4 below and the 
further subjected to data treatment to arrive at statistically 
significant factors that impact the formulation design. The 
12th hour dissolution was performed only to arrive at 
profile across the time range but this response was not used 
for data analysis and optimization in the DOE. 
 
 
Figure 4: DOE Experimental design and responses 
 
The Quadratic model was chosen for fitting the data as it is 
the most preferred model for fitting the CCD design and no 
aliases were found in the model. Since the model chosen is 
quadratic, a second order polynomial would be used for 
predicting the response functions. 
Y = β0 + β1A+β2B+β3A2+β4B2+β5AB 
Where, Y is the response, A and B are independent 
variables and β0 to β5 are the constants or coefficients 
for each term in the equation. The responses desired in the 
study were dissolution at time points equivalent to 1, 4, 8 
and 20 hours and the table 1 below depicts the low and high 
values for the variables (as chosen in the study) and 
responses (as achieved by experimentation). It can be 
observed that the ratio of maximum to minimum in case of 
all responses is less than 2.0. Hence the data does not 
require any transformation. 
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Table 1: Response compilation in DOE 
Name Units Type Desired 
Response 
Low High Std. Dev Ratio of Max To 
min Polymer conc mg Factor - 300 400 NA NA 
Drug content % Factor - 11 19 NA NA 
1 hrs % Dissolved Response < 25 % 12.4 19 0.3006 1.492 
4 hrs % Dissolved Response 20 – 40 % 33.5 43.3 2.0381 1.293 
8 hrs % Dissolved Response 40 – 60 % 55 70.6 1.6746 1.284 
20 hrs % Dissolved Response 80 – 100 % 82.1 100 4.3736 1.218 
The results obtained for each of the responses are mentioned in the table 2. The selected model for each response is 
underlined. 
Table 2: Sequential Model sum of Squares 
Response Model F Value P value 
D @ 1 hour 
Linear 2.26 0.1665 
2FI 0.92 0.3704 
Quadratic 99.06 <0.001 
Cubic 0.18 6.61 
D @ 4 hours 
Linear 5.77 0.02 
2FI 0.58 0.4696 
Quadratic 3.82 0.0983 
Cubic 46.37 * 0.0055 
D @ 8 hours 
Linear 5.54 0.0309 
2FI 5.46 0.9432 
Quadratic 18.06 0.0052 
Cubic 0.0043 0.9589 
D @ 20 hours 
Linear 1.25 0.3368 
2FI 5.02 0.0600 
Quadratic 0.40 0.6886 
Cubic 282.36 * 0.0004 
* cubic model is aliased for a central composite design. Hence design augmentation required to remove the alianses and 
estimate the higher order terms. Hence here, the next best F value model is selected for evaluation. 
The complete ANOVA output for all the responses is described later in table 3, 4 and 5. Here also a higher F value and p value 
less than 0.1 (preferably < 0.05) indicates a significant model chosen for the data. 
Table 3: ANOVA output for response surface - Model 
Response Model Model F 
Value 
P value Significant 
model terms 
Final equation in 
terms of coded 
factors 
D-1 hour Quadratic 70.92 0.001 A, B, AB, A2, 
B2 
+15.18-1.35* A+0.37* B-0.78* A 
* B 1.76*A2+2.39* B2 D-4 hours Linear 5.77 0.02…81 A, B +38.77 -2.28  
A+1 .67 * B D-8 hours Quadratic 
with model 
reduction for A2 
14.51 0.0031 A, B, B2 +57.22-3.98*A 
+3.28* B - 0.15 * A * B + 5.73 * 
B2 
D-20 hours 2 FI 2.93 0.109 A, B +91.45 -2.97  A  
1 .78* B-4.90*A * B  
If extra design points beyond what‘s needed for the model 
are added, and some points were replicated to provide an 
estimate of pure error, the results of a Lack of Fit test for 
each model also can be calculated. Lack of Fit compares the 
residual error (MEAN SQUARE) to the pure error (MEAN 
SQUARE). Lack of fit is NOT desirable so a small F value and 
p value greater than 0.05 (preferably < 0.1) are desired. If a 
model shows significant lack of fit, it should not be used to 
predict the response. The lack of fit calculation for the four 
responses is described in the table 4 below.
 
Table 4: Model Lack of Fit calculation for four responses 
Response Model Chosen F Value P value Character 
D @ 1 hour Quadratic 3.10 0.2534 In-significant 
D @ 4 hours Linear 87.12 0.1114 Marginally Significant 
D @ 8 hours Quadratic 16.03 0.0593 In- significant 
D @ 20 hours 2FI 131.30 0.0076 Significant 
 
The other objective can be where the primary concern is to 
simply identify factors and interactions that are affecting 
the response and generally just learn if higher or lower 
factor levels are better (generally with factorial designs). In 
this case, there might have the situation where the model is 
statistically significant and there is no lack of fit, but the R-
squared's are low. It can be concluded that the significant 
terms identified are correct and the graphs will show the 
best directions to follow, but all the sources of variation are 
not found (and hence not controlled) in the formulation or 
process. There are other things left unidentified which may 
or may not also give even better results. So, there is no 
doubt that the factors found are correct and their model is 
adequate, but there is more to be investigated. When the R- 
squared values are low then the model should not be used 
for prediction as it doesn't explain enough of what is going 
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on in totality. A good next step would be to set the known 
factors at their best settings and then brain-storm about 
other possible factors and run another DOE. The R square 
values for all four responses are compiled in the table 5 
below.
 
Table 5 : R2 Values for all four responses 
Response R2 R2 Adjusted R2 Predicted Adequate precision PRESS 
D @ 1 hour 0.9861 0.9722 0.8745 28.065 4.08 
D @ 4 hours 0.5906 0.4883 0.1117 7.442 71.63 
D @ 8 hours 0.9861 0.9043 0.8439 12.225 56.26 
D @ 20 hours 0.5564 0.3332 -0.9814 5.996 598.05 
 
As is described in the table above, the cubic model showed 
better F values fo the D@4 hours and D@20 hours 
indicating higher order terms impacting the responses. 
Since the D@ 20 hours response is the final time point in 
the dissolution and the specification of Dissolution > 80% 
meets for all points across the design points this response 
need not be used for predictive purposes. Also, the low 
predictability observed for D@4 hours can be overlooked as 
it has a brackting of D@1 hour and D@8 hours which in 
turn can be predicted acturately from the model. But a final 
full proof solution to better fitting of data to all responses 
would be to augment the design to better estimate higher 
order terms to fit the cubic model to these two responses. 
The current work limits to identification of the significant 
factors for responses D@4 hours and D@20 hours and 
ascertains that the predictive power of the model is low for 
these responses. 
The normal probability The Normal probability plots for 
the four responses are plotted in figure 5 & 6 depict that the 
distribution is uniform and there is no specific pattern in 
the distribution. 
 
 
Figure 5: Normal probability plots 
 
Figure 6: Residuals vs Predicted 
Shah et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):551-561  
ISSN: 2250-1177                                                                                  [556]                                                                                 CODEN (USA): JDDTAO 
 
The DOE software analyses the differences between the 
actual values obtained for experimental runs and the 
predicted values one would have arrived at if the models 
were used to predict the response at the set of factor 
combinations corresponding to the runs. The details for each 
of the responses are compiled in the table 6 and 7.
 
Table 6: Predicted vs Actual Compilation – Response D@ 1hour and D@ 4 hours 
 Standard 
Order 
D @ 1 Hour D @ 4 Hours 
Actual 
value 
Predicted 
value 
Residual 
Actual 
value 
Predicted 
Value 
Residual 
1 16.2 16.0214 0.178 39.9 39.389 0.510 
2 14.7 14.8714 -0.171 34.8 34.822 -0.022 
3 18.5 18.3048 0.195 43.3 42.722 0.577 
4 13.9 14.0548 -0.154 41.4 38.156 3.243 
5 14.4 14.7736 -0.373 40.2 41.056 -0.856 
6 12.4 12.0736 0.326 33.5 36.489 -2.989 
7 17.2 17.2070 -0.007 40.1 37.106 2.993 
8 17.9 17.9403 -0.0403 40.1 40.439 -0.339 
9 15 15.1842 -0.184 38 38.772 -0.772 
10 15.2 15.1842 0.0157 37.5 38.772 -1.272 
11 15.4 15.1842 0.215 37.7 38.772 -1.072 
 
Table 7: Predicted vs Actual Compilation – Response D@ 8 hour and D@ 20 hours 
Standard 
Order 
D @ 8 Hours D @ 20 Hours 
Actual 
value 
Predicted 
value 
Residual Actual 
value 
Predicted 
value 
Residual 
1 63.6 63.5 0.100 88 90.08 -2.082 
2 55.6 55.833 -0.233 94.1 93.94 0.152 
3 70.6 70.366 0.233 95.6 100.41 -4.815 
4 62 62.1 -0.100 82.1 84.68 -2.582 
5 63.6 61 .203 2.397 96.3 95.248 1.052 
6 56.3 53.236 3.063 85.9 89.31 -3.415 
7 59.8 59.666 0.133 94 92.015 1.985 
8 66.1 66.233 -0.133 100 92.548 7.452 
9 55 57.22 -2.220 93.5 92.28 1.218 
10 56 57.22 -1.220 93 92.28 0.718 
11 55.2 57.22 -2.020 92.6 92.28 0.318 
 
The residual values in the tables above indicate that there is 
no significant variation in the actual responses obtained and 
those predicted by the model. The Predicted Vs Actual plots 
for all responses are depicted in the figure 7. It can be 
observed that the predicted vs actual point are more closer 
to the line for responses D@ 1 hour and D @ 8 hours 
indicating better fit of model to the data. The points are more 
scattered and away from the line for the D @ 4 hours and D 
@ 20 hours reponses reconfirming that the models chosen is 
not a perfect´ fit for predicting the data for these two 
responses. As indicated above, the augmentation of design is 
a better alternative to further fit these responses to a higher 
order model. 
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Figure 7: Predicted vs Actual Plots 
 
The perturbation plot helps to compare the effect of all the 
factors at a particular point in the design space. The 
response is plotted by changing only one factor over its 
range while holding of the other factors constant. By 
default, Design-Expert software sets the reference point at 
the midpoint (coded 0) of all the factors. But it can be 
changed to any point (perhaps the optimal run conditions) by 
using other Factors Tool in the software. A steep slope or 
curvature in a factor shows that the response is sensitive to 
that factor. A relatively flat line shows insensitivity to 
change in that particular factor. If there are more than two 
factors, the perturbation plot could be used to find those 
factors that most affect the response. These influential 
factors are good choices for the axes on the contour plots. 
This plot is like "one factor at a time" experimentation – it 
does not show you the effects of interactions. Since this 
study was carried out with only two factors, the 
perturbation plots were used to only study the effect of 
factors on the responses and not to narrow down the 
influential factors for the contour plots. The figure 8 depicts 
the perturbation plots for all the four responses while 
keeping the factors at midpoint levels. 
 
 
Figure 8: Perturbation Plots 
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These perturbation plots show that all the responses are 
sensitive to the factors as in all cases there is a visible steep 
slope or curvature in the response plots. After evaluating 
the perturbation, the factors can now be used to generate 
2D contour plots and 3D response surface plots. It can also 
be reconfirmed from the perturbation plots that D@1 hour 
and D@ 8 hours are quadratic responses as they show a 
curve wheres D @ 4 hours and D @ 20 hours show a 
straight line indicating linearity (in given experimental 
data). Also a greater curvature and significant slope for the 
linear response indicate that both factors have impact on 
each of the responses. The Contour plots for the four 
responses are plotted in the figures. Each line on the 
contour represents the same responses at the combination 
of the two factor levels. 
It can be seen that at higher polymer concentrations, and 
around 13 to 17 % of drug content can help achieve 
minimum dissolution value at the 1hour time point. Also, at 
all of the factor combinations, the dissolution does not go 
beyond the desired limit of 25 % indicating that the chosen 
factor levels are competent to achieve the desired 
response. The corresponding 3D response surface for this 
response is depicted below for better interpretation and 
visualization of the response surface. It can be observed 
that the contours for the D @ 4 hours response are linear. 
It can also be seen that towards lower polymer 
concentration (less than 325 mg) and at higher drug % ( 
greater than 16 %), the dissolution value is above 40 % (as 
against the desired limit of 20 – 40 %). Hence to be safely 
inside the limit, one has to choose a higher polymer 
concentration (greater than 375mg) and lower drug 
concentration (between 11 to 13 %) to have a lower 
dissolution value as shown by the 36 % contour at bottom 
right corner in the above figure. The 3D response surface 
for this response also helps interpret a linear relationship 
and the graph is depicted in figure. 
The contour plot for the D @ 8 hours response is again a 
curvature-based plot indicating higher order terms. The 
contour indicates desired reponse above 350 mg polymer 
concentration and between 11 to 15 % drug content. In 
this plot too, at lower polymer concentration and above 15 
% drug content, the dissolution value tends to rise above 
the spec limit (i.e. 60 %). The contour and the 
corresponding 3D response surface for D @ 8 hours 
response is depicted in figures. Although, the response 
surface is not a good predictor for the response D @ 20 
hours, the contour and 3D response surface were 
constructed to visualize the effect of factors combinations 
on to the response. This contour plot does not show any 
pattern (curvature or linearity) with respect to the 
responses.
  
 
Figure 9: Contour plot with 3D response in 1 hour and 4 hours 
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Figure 10: Contour plot with 3D response in 8 hour and 20 hours 
 
OPTIMIZATION:  
The optimization module in Design-Expert searches for a 
combination of factor levels that simultaneously satisfy the 
requirements placed on each of the responses and factors. It 
can be only be used when each response has been analyzed 
independently to establish the appropriate model. 
Optimization of one response or the simultaneous 
optimization of multiple responses can be performed 
graphically or numerically. Also, one can simultaneously 
evaluate all the response models for any value of the 
independent variables using the point prediction node. 
Numerical Optimization: The table 8 below compiles the 
Numerical optimization criteria for each response in order 
to carry out numerical optimization. 
 
Table 8: Numerical Optimization constraints 
Name Goal Lower Limit Upper Limit Weight 
Polymer conc Is in range 300 400 3 
Drug content Is in range 11 19 3 
1 hrs Is in range 10 20 3 
4 hrs Is in range 30 40 3 
8 hrs Is in range 40 60 3 
20 hrs Is in range 80 100 3 
The figure 11 below shows the screen shot of possible solutions suggested by the software design expert ® after considering 
the desired constraints during numerical optimization of the design. 
 
Graphical Optimization: With multiple responses one 
needs to find regions where critical properties. By 
superimposing or overlaying critical response contours on a 
single plot we can visually search for the best combination. 
When dealing with many input variables, its better to do 
numerical optimization first, otherwise its impossible to 
uncover a feasible region. Graphical optimization displays 
the area of feasible response values in the factor space. 
Regions that do not fit the optimization criteria are shaded. 
For multiple responses we may see several overlapping 
shaded areas. Any "window" that is NOT shaded satisfies 
the multiple constraints on the responses. The figure 11 
depicts the overlaying contours for each response meeting 
the criteria set in table 8 above The region (yellow) depicts 
the design space´ for achieving the set of responses with the 
factor combinations.requirements simultaneously meet the 
critical properties. By superimposing or overlaying critical 
response contours on a single plot we can visually search 
for the best combination. When dealing with many input 
variables, its better to do numerical optimization first, 
otherwise its impossible to uncover a feasible region. 
Graphical optimization displays the area of feasible 
response values in the factor space. Regions that do not fit 
the optimization criteria are shaded. For multiple responses 
we may see several overlapping shaded areas. Any 
"window" that is NOT shaded satisfies the multiple 
constraints on the responses. The figure 11 depicts the 
overlaying contours for each response meeting the criteria 
set in table 8 above The region (yellow) depicts the design 
space´ for achieving the set of responses with the factor 
combinations. 
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Figure 11: Graphical optimization overlay showing the Design Space 
 
Validation of the model: The validation of the model was 
carried out using the point prediction´ tool in the design 
expert software. The tool can be used to predict the response 
by varying the factor combinations. A setting of factors was 
chosen in the design space and replicated 3 times to 
determine the error in predictability of the design and to 
determine the predicted vs actual variation of the model. 
The table 9 describes the factor combinations chosen and 
their predicted vs the actual response. 
 
Table 9: Predicted vs Actual responses 
Trial Factor Response Predicted value Actual value 
Residual 
(Actual –Predicted) 
1 
Polymer 
concentration  
(350 mg; Drug Content) 15 
% 
1 hour 15.1959 
15.3 - 
- -0.1041 
- - 
15.2 -0.0041 
16 -0.8041 
37.5 1.3178 
4 hours 
38.8178 
37.8 1.0178 
38.2 0.6178 
8 hours 57.3129 
56.4 0.9129 
57.5 -0.1871 
58.4 -1.0871 
92 -0.4973 
20 hours 91.5027 
91.5 0.0027 
93.5 -1 .9973 
 
It can be seen that the data of predicted vs actual are in 
reasonable agreement of each other. Thus, the model can be 
used to navigate the design space successfully. 
SUMMARY AND CONCLUSIONS 
The Polyethylene oxide polymers provide a very unique 
processing advantage over other conventional polymers 
used in modified release formulation systems. The 
concentration of the polymer and its grade chosen are the 
most important factors that affect the formulation design 
and they have to be chosen based on the desired product 
performance. The combinations of two viscosity grades do 
not significantly impact the dissolution of the drug from the 
system. The use of a high dose highly water-soluble drug 
presents an added challenge to formulate a modified release 
dosage form. Initial experiments were carried out to arrive 
at factors critical to the formulation in order to meet the 
desired release criteria. From the results obtained in these 
trials the polymer was chosen to be PEO WSR 303 and its 
concentration and the % drug content of the total tablet 
weight were chosen to be the factors most affecting the 
formulation performance. A structured optimization study 
was undertaken using the Design of experiments approach. 
A Two factor 3 level face centered Central composite design 
was chosen with polymer concentration and % drug 
content being the two factors. The polymer concentration 
was varied from 300 to 400 mg per tablet and the drug 
content between 11 to 19 % of the tablet weight. 
Dissolution at 1, 4, 8- and 20-hours’ time points was chosen 
as the output responses to determine the % drug release. 
The experimental runs were executed and the results 
obtained subjected to data treatment and multivariate 
analysis. The statistical correlations were drawn based on 
the predictive and suggestive tools in the DOE choosing the 
Shah et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):551-561  
ISSN: 2250-1177                                                                                  [561]                                                                                 CODEN (USA): JDDTAO 
 
statistical models for predicting each of the responses. The 
Dissolution at 1 hour and 8 hours followed a quadratic 
model whereas the models chosen for dissolution at 4 hours 
and dissolution at 20 hours were estimated a linear and 2FI 
model respectively. The ANOVA was calculated to 
determine the significant factors in the model that affect the 
response outcomes. After fitting of data to the selected 
models optimization was carried out for achieving the 
target product profile. The repeatability of the experiments 
was evaluated by choosing a point in the design space and 
replicating 3 times to determine the inter response 
variations and the difference was found to be statistically 
in-significant. The design of experiments (DOE) approach 
was thus used to optimize the polyethylene oxide based 
modified drug delivery system to meet the target product 
profile for the highly water soluble compound of Metoprolol 
succinate. 
Value addition of this work 
The fundamentals and basics of DOE (Design of experiment) 
learned during this work can be applied to other projects 
where meeting the desired target product profiles is highly 
critical. Although, Metoprolol succinate was used as a model 
drug, the PEO based platform technology can be applied 
with minor modifications to other compounds with similar 
properties in order to meet the target specifications. 
Developing a PEO based modified release drug delivery 
system can in turn help circumvent the innovator IP and 
reduce the formulation and process time involved in 
development thus saving cost and improving throughput 
responses. 
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